Clinical Trial Update: Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal Cancer [NA]

View source ↗

Summary

A clinical trial evaluating high-dose-rate endorectal brachytherapy for locally advanced low rectal cancer has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Rectal Cancer | NA | Status: COMPLETED | Results posted: 2020-09-14